$SOTK

Sono-Tek Reports Fiscal Second Quarter Financial Results and Record First Half 2026 Revenue

- Reports Sixth Consecutive Quarter of Revenue over $5 million Highlighted by 150% Annual Increase in Medical Market Sales- -Updates FY26 Guidance Reflecting Improved Outlook, Anticipating Modest Revenue Growth with Increasing Demand in the Medical Device Market-

Original reporting
GlobeNewswire · Sono-Tek Corporation
Published Oct 14, 2025, 11:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Oct 14, 2025, 12:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sono-Tek Reports Fiscal Second Quarter Financial Results and Record First Half 2026 Revenue — source image
Decision brief

The 30-second read

$SOTKBullishHigh
01

Why it matters

The positive financial results reinforce the company's growth trajectory, potentially attracting more investor interest and supporting stock price appreciation.

02

Market read

The news is highly relevant for investors interested in medical manufacturing stocks, with immediate implications for SOTK.

03

What to watch

Potential supply chain constraints or increased competition could impact future revenue growth; macroeconomic factors may also influence market sentiment.

Timing: immediate, as the news is recent and reflects current financial performance.

Background

Sono-Tek has demonstrated consistent revenue growth over multiple quarters, with recent results highlighting increased demand in the medical sector.

Company-level read

Ticker impact

$SOTKBullishHigh confidence
Context

The news pertains directly to Sono-Tek Corporation, indicating strong relevance for this ticker.

Expected impact

Potential short-term upward movement, with a moderate increase expected over the next 1-3 months.

Evidence & confidence

Consistent revenue growth and positive outlook suggest a solid performance trajectory, supported by industry trends in medical device demand.

Market effects

The manufacturing sector, particularly medical device manufacturing, may experience increased investor interest due to Sono-Tek's strong performance.

Limited regional impact; primarily relevant to investors focusing on the company's domestic and global markets.

Moderate; reflects broader trends in medical technology demand but limited direct influence on global markets.

Counterpoint

Some analysts may caution that the record revenue figures could be a short-term spike, and future growth may slow if market demand plateaus.

Key entities

  • Sono-Tek Corporation

    A manufacturer specializing in ultrasonic coating systems for various industries.

  • Medical Device Market

    A sector experiencing increased demand, contributing to Sono-Tek's revenue growth.

Related articles

$SOTKMedAI 8/10

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.

$SOTKMed

SONO TEK CORP (SOTK): Results of Operations and Financial Condition

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati

$SOTKMedAI 9/10

Sono-Tek Corporation Q4 2026 Earnings Call Summary

Sono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.

$SOTKMedAI 9/10

Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Sono-Tek (Nasdaq: SOTK) reported FY2026 net sales of $20.9M (+2% YoY), gross margin of 51% (up from 47.5%), operating income of $1.82M (+81%), and net income of about $1.8M (+42%), according to the company. Q4 net sales were $5.6M (+10%). Backlog was $9.1M. The company expects continued 1H FY2027 revenue growth driven by medical and high-ASP systems; FY2027 revenue projected flat to modestly higher.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.